SPRED3 and thyroiditis: The results showed that SPRED3 expression significantly differed according to clinical stage (T1/2 vs. T3/4), lymph node invasion (N0 vs. N1), primary tumor tissue type, external thyroid gland invasion, tumor residue, tumor location and previous thyroid history (Table 1).